MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 03.11.2025
Land |
 Vereinigte Staaten |
IPO-Jahr |
2001 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ CAPITALSPB |
Anteile |
185 M |
Marktkapitalisierung |
$ 18.8 B |
EBITDA (LTM) |
$ -40 M |
P/E (LTM) |
-118.16 |
P/S (LTM) |
6.12 |
EPS (LTM) |
-0.86 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Brainsway Ltd.
BWAY
|
$ 22.03 | 3.19 % | $ 99.4 M | Nasdaq Global Select Market |  Israel |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Burning Rock Biotech Limited
BNR
|
$ 22.9 | 19.89 % | $ 246 M | Nasdaq Global Market |  China |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
BioNano Genomics
BNGO
|
$ 1.6 | -0.62 % | $ 2.03 M | Nasdaq Capital Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Co-Diagnostics
CODX
|
$ 6.05 | 6.14 % | $ 178 M | Nasdaq Capital Market | USA |
 |
Castle Biosciences
CSTL
|
$ 40.8 | 1.83 % | $ 1.13 B | Nasdaq Global Market,SPB | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Danaher Corporation
DHR
|
$ 234.89 | -0.73 % | $ 172 B | NYSE,SPB | USA |
 |
DarioHealth Corp.
DRIO
|
$ 12.11 | -10.18 % | $ 344 M | Nasdaq Capital Market | Israel |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
DexCom
DXCM
|
$ 70.15 | 0.37 % | $ 27.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
CareDx, Inc
CDNA
|
$ 18.99 | 0.96 % | $ 1.02 B | Nasdaq Global Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 27.97 | 7.62 % | $ 846 M | Nasdaq Global Market | USA |
 |
Celcuity
CELC
|
$ 109.72 | 4.47 % | $ 4.33 B | Nasdaq Global Select Market | USA |
 |
Anixa Biosciences
ANIX
|
$ 3.26 | 2.4 % | $ 104 K | Nasdaq Capital Market | USA |
 |
Guardant Health
GH
|
$ 110.12 | -1.97 % | $ 13.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 29.05 | 1.22 % | $ 20 B | NYSE |  Niderland |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
IQVIA Holdings
IQV
|
$ 244.09 | 1.5 % | $ 44.3 B | NYSE,SPB | USA |
 |
Illumina
ILMN
|
$ 151.07 | 2.65 % | $ 24 B | Nasdaq Global Select Market,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 216.28 | - | $ 11.1 B | NYSE,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 178.22 | -1.22 % | $ 19.8 B | NYSE,SPB | USA |
|
Biodesix
BDSX
|
$ 5.86 | -2.82 % | $ 760 M | Nasdaq Global Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 253.83 | -2.49 % | $ 21.3 B | NYSE,SPB | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
ICON Public Limited Company
ICLR
|
$ 202.64 | 0.58 % | $ 16.7 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
$ 710.27 | 0.49 % | $ 58.6 B | Nasdaq Global Select Market,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 69.22 | -0.66 % | $ 4.79 B | Nasdaq Global Select Market,SPB | USA |
 |
Agilent Technologies
A
|
$ 147.47 | -0.1 % | $ 44.8 B | NYSE,SPB | USA |
 |
Biomerica
BMRA
|
$ 2.78 | 5.41 % | $ 6.39 M | Nasdaq Capital Market | USA |
 |
Bioventus
BVS
|
$ 7.56 | -1.18 % | $ 474 M | Nasdaq Global Select Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | Israel |
 |
QIAGEN N.V.
QGEN
|
$ 47.23 | 0.32 % | $ 10.5 B | NYSE | Niderland |
 |
Mettler-Toledo International
MTD
|
$ 1 462.87 | -1.54 % | $ 31 B | NYSE,SPB |  Schweiz |
 |
Myriad Genetics
MYGN
|
$ 6.7 | 2.68 % | $ 607 M | Nasdaq Global Select Market,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 4.51 | -1.96 % | $ 2.42 M | Nasdaq Global Select Market | USA |
 |
NeoGenomics
NEO
|
$ 12.69 | -0.78 % | $ 1.61 B | Nasdaq Global Select Market,SPB | USA |